No Data
No Data
Xiamen Kingdomway Group (002626.SZ): Obtained a certificate for one invention patent.
On July 15th, Gelonhui reported that Xiamen Kingdomway Group (002626.SZ) and its wholly-owned subsidiaries Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. and wholly-owned subsidiary Kingdomway Biotechnology (Jiangsu) Co., Ltd. have recently received a patent certificate issued by the State Intellectual Property Office for an invention entitled "Pan-succinic acid synthase mutant and its preparation method, construction body and its construction method, pan-succinic acid-producing strain and its application, and preparation method of pan-succinic acid". This invention belongs to the technical field of D-pan-succinic acid synthesis and discloses a mutant of pan-succinic acid synthesis enzyme and its preparation method, construction body and its construction method, pan-succinic acid-producing strain and its application, and preparation method of pan-succinic acid.
What You Can Learn From Xiamen Kingdomway Group Company's (SZSE:002626) P/E
Xiamen Kingdomway Group Company's (SZSE:002626) price-to-earnings (or "P/E") ratio of 33.8x might make it look like a sell right now compared to the market in China, where around half of the companie
Subsidiary of Xiamen Kingdomway Group (002626.SZ) obtained food production license.
Xiamen Kingdomway Group (002626.SZ) announced that its wholly-owned subsidiary, Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. (hereinafter referred to as ...
Xiamen Kingdomway Group (002626.SZ): The company's production capacity of vitamin D3 is 1600 tons.
On June 25th, Gelonhui reported that Xiamen Kingdomway Group (002626.SZ) stated on the investor interaction platform that the company's vitamin D3 production capacity is 1600 tons (equivalent to 500,000 IU/g specifications). The revenue proportion of the company's vitamin D3 is relatively small, and the output does not meet the disclosure requirements.
Xiamen Kingdomway Group's Q1 2024 financial report: analysis of financial data and performance.
As a leading enterprise in health food and fodder additives, Xiamen Kingdomway Group (stock code: 002626) has a complete industry chain layout covering various links from raw material supply to brand operation. Recently, the company released its Q1 2024 financial report. This article will conduct an in-depth analysis from the aspects of asset and liability data, profit data, and cash flow data to explore the company's latest performance. From the asset and liability data, Kingdomway's total assets at the end of this period were 5.561 billion yuan, a 3.88% increase from the beginning of the period, indicating steady expansion of the company's scale. Among them, the end-of-period balance of goodwill slightly increased to 487 million yuan, indicating that the company's...
Doctor's Best Inc. Acquires Viactiv Brand
Headquarters will be Based in Tustin, Calif. TUSTIN, Calif., June 11, 2024 /PRNewswire/ -- Doctor's Best, one of the nation's leading marketers of nutritional supplements and a wholly-owned subsidiar
No Data